SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-030776
Filing Date
2024-03-13
Accepted
2024-03-13 16:12:46
Documents
13
Period of Report
2024-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20240310.htm   iXBRL 8-K 55832
2 EX-99.1 sprb-ex99_1.htm EX-99.1 151595
  Complete submission text file 0000950170-24-030776.txt   347475

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20240310.xsd EX-101.SCH 31969
14 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240310_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 24746044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)